| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/23/2003 | WO2003006996A2 Natural ligand of gpcr chemr23 and uses thereof |
| 01/23/2003 | WO2003006988A1 Cardiovascular safety assay |
| 01/23/2003 | WO2003006689A2 Diagnosis and treatment of diseases associated with altered expression of hipk1 |
| 01/23/2003 | WO2003006688A2 Methods for diagnosis and treatment of diseases associated with altered expression of gnas |
| 01/23/2003 | WO2003006680A2 Omi and domains thereof that disrupt iap-caspase interaction |
| 01/23/2003 | WO2003006679A2 52908, a human potassium channel, and uses thereof |
| 01/23/2003 | WO2003006674A2 CRYSTALS AND STRUCTURES OF ArnB AMINOTRANSFERASES |
| 01/23/2003 | WO2003006673A2 A nucleic acid encoding a human junctional adhesion protein (jam3) |
| 01/23/2003 | WO2003006672A2 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same |
| 01/23/2003 | WO2003006671A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | WO2003006668A2 Haptoglobin Derived Antioxidants |
| 01/23/2003 | WO2003006665A1 Lawsonia intracellularis |
| 01/23/2003 | WO2003006661A2 Transgenic plants expressing cobalamin binding proteins |
| 01/23/2003 | WO2003006659A2 Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof |
| 01/23/2003 | WO2003006654A2 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 01/23/2003 | WO2003006653A1 Mycoplasma spp. a39 |
| 01/23/2003 | WO2003006649A2 Expression system |
| 01/23/2003 | WO2003006641A2 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 01/23/2003 | WO2003006640A1 A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 01/23/2003 | WO2003006639A1 Cell and transgenic animal modelling human antigenic presentation and their uses |
| 01/23/2003 | WO2003006630A2 Nucleic acid free ghost preparations |
| 01/23/2003 | WO2003006626A2 CRYSTAL STRUCTURE OF A MarR FAMILY POLYPEPTIDE |
| 01/23/2003 | WO2003006624A2 47619 and 47621, human ion channels, and uses thereof |
| 01/23/2003 | WO2003006622A2 Nuclear fertility restorer genes and methods of use in plants |
| 01/23/2003 | WO2003006621A2 Super osteocalcin promoter for the treatment of calcified tumors and tissues |
| 01/23/2003 | WO2003006620A2 Linear and cyclic melanocortin receptor-specific peptides |
| 01/23/2003 | WO2003006619A2 Calcineurin modulators |
| 01/23/2003 | WO2003006618A2 Nucleic acid-associated proteins |
| 01/23/2003 | WO2003006617A2 Crystals and structures of perosamine synthase homologs |
| 01/23/2003 | WO2003006615A2 Method of making fgf-12 and kgf-2 |
| 01/23/2003 | WO2003006609A2 Human cytokine receptor |
| 01/23/2003 | WO2003006607A2 Inhibition of apoptosis process and improvement of cell performance |
| 01/23/2003 | WO2003006606A2 Targeted fusion proteins and methods for the characterization of cellular membrane domains |
| 01/23/2003 | WO2003006605A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | WO2003006604A2 Cyclic peptides as potent and selective melanocortin-4 receptor agonists |
| 01/23/2003 | WO2003006603A2 Triple polypeptide complexes |
| 01/23/2003 | WO2003006531A1 Keratin-based products and methods for their productions |
| 01/23/2003 | WO2003006506A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/23/2003 | WO2003006505A1 Factor viii separation |
| 01/23/2003 | WO2003006504A2 Allelic variants of gpr50 |
| 01/23/2003 | WO2003006503A1 Chimeric g protein coupled receptors |
| 01/23/2003 | WO2003006502A2 Isolation, characterization, and use of a teleost potassium channel |
| 01/23/2003 | WO2003006501A2 G-csf conjugates |
| 01/23/2003 | WO2003006500A1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 01/23/2003 | WO2003006499A2 Survivin interacting protein tpr1 |
| 01/23/2003 | WO2003006498A2 Oncosuppressive gene |
| 01/23/2003 | WO2003006497A2 Mutated photoproteins and their uses |
| 01/23/2003 | WO2003006496A2 Protein variants of neocarzinostatine and its homologues and their use |
| 01/23/2003 | WO2003006495A2 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 01/23/2003 | WO2003006493A2 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | WO2003006492A2 Biologically active peptides |
| 01/23/2003 | WO2003006491A2 Peptide-based compounds for targeting intergin receptors |
| 01/23/2003 | WO2003006486A2 Bcr-abl oligomerization domain polypeptides and uses therefor |
| 01/23/2003 | WO2003006485A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | WO2003006484A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | WO2003006483A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | WO2003006481A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | WO2003006480A1 Tetrahymena metallothionein gene promoter and its use |
| 01/23/2003 | WO2003006479A1 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 01/23/2003 | WO2003006154A2 Protein design automation for designing protein libraries with altered immunogenicity |
| 01/23/2003 | WO2003006070A2 Improved chelator conjugates |
| 01/23/2003 | WO2003006067A2 Composition comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis |
| 01/23/2003 | WO2003006056A2 End-locked five-helix protein |
| 01/23/2003 | WO2003006048A1 Combination of chips (chemotaxis inhibiting protein from staphylococcus aureus)-based compounds |
| 01/23/2003 | WO2003006047A2 Methods for reducing immunogenicity of polypeptides |
| 01/23/2003 | WO2003006045A2 Cxcl10 treatment of secondary tissue degeneration |
| 01/23/2003 | WO2003006044A1 Methods and compositions for controlling protein assembly or aggregation |
| 01/23/2003 | WO2003006043A1 Surfactant peptide nanostructures, and uses thereof |
| 01/23/2003 | WO2003005964A2 Recombinant vsv for the treatment of tumor cells |
| 01/23/2003 | WO2003005958A2 Hypertension associated transcription factors and uses therefor |
| 01/23/2003 | WO2003005957A2 Mutants of clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith |
| 01/23/2003 | WO2003005956A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/23/2003 | WO2003005955A2 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 01/23/2003 | WO2003005953A2 Viral proteins capable of binding lar |
| 01/23/2003 | WO2003005888A2 Lipophilin complexes for use in cancer diagnosis and therapy |
| 01/23/2003 | WO2003005880A2 Replikin peptides and uses thereof |
| 01/23/2003 | WO2003005819A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 01/23/2003 | WO2002098908A9 Osteoclastogenesis inhibitory factor, sequence coding for it and uses |
| 01/23/2003 | WO2002094867A8 Sequence of the photorhabdus luminescens strain tt01 genome and uses |
| 01/23/2003 | WO2002088302A3 Method for secreting proteins by bacteria, leader sequences and vectors for carrying out said method |
| 01/23/2003 | WO2002086058A3 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 01/23/2003 | WO2002083726A3 A novel zinc finger protein and uses thereof |
| 01/23/2003 | WO2002080842A3 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis |
| 01/23/2003 | WO2002077153A3 The human psychosine receptor |
| 01/23/2003 | WO2002072827A9 Traf3-binding b cell-specific receptor |
| 01/23/2003 | WO2002072005A3 Linear y-carboxyglutamate rich conotoxins |
| 01/23/2003 | WO2002064740A9 Cone snail peptides |
| 01/23/2003 | WO2002062947A9 Hematopoietic growth factor inducible neurokinin-1 gene |
| 01/23/2003 | WO2002053711A3 Use of transcription factor yb-1 in adenoviral systems |
| 01/23/2003 | WO2002052030A3 Compositions and methods enabling a totally internally controlled amplification reaction |
| 01/23/2003 | WO2002050302A3 Protein-protein interactions |
| 01/23/2003 | WO2002048388A9 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 01/23/2003 | WO2002048313A3 Senescence-associated plant promotors |
| 01/23/2003 | WO2002046400A3 Mutated class ii major histocompatibility proteins |
| 01/23/2003 | WO2002046364A9 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/23/2003 | WO2002038592A3 Peptides, the production and use thereof for binding immunoglobulins |
| 01/23/2003 | WO2002036790A3 Influenza virus vector for infection of dendritic cells |
| 01/23/2003 | WO2002034927A3 Plant genes that confer resistance to strains of magnaporthe grisea having avr1 co39 cultivar specificity gene |
| 01/23/2003 | WO2002034778A3 Baseb209 polypeptides and polynucleotides from haemophilus influenzae |
| 01/23/2003 | WO2002034768A3 Polypeptides and polynucleodides from haemophilus influenzae and their use |